MONCYTE Health has secured €1 million in seed funding to enhance its personalized treatment technology for high cholesterol, a major cardiovascular risk factor. The investment, led by Finnish venture capital firms, aims to advance a unique diagnostic approach that quantifies cellular lipid uptake, enabling tailored therapies for patients. This innovative technology promises to improve cholesterol management and reduce cardiovascular disease risk by providing insights into the cellular mechanisms involved.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
